Home/ Supplements/ Vitamin K/ MK-7 Plus with K1 & MK-4

MK-7 Plus with K1 & MK-4

product on market Capsule NOW Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 75% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

This formula combines Vitamin K1 and K2 (MK-7 and MK-4), which are supported by strong evidence for regulating blood clotting and bone mineralization. Alfalfa powder provides additional nutrients, though its specific clinical impact in this blend is less documented. The ingredient profile maintains a high safety rating for most users.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for MK-7 Plus with K1 & MK-4
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Veg Capsule(s)
Serving Size
90
Servings
Botanical with Nutrients
Product Type
75%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

120 mcg (100% DV)
Within RDA (1.0× RDA) 275 studies (A:9, B:175)
360 mcg
3.0× RDA — within safe limits 275 studies (A:9, B:175)
90 mcg
Within RDA (0.8× RDA) 275 studies (A:9, B:175)
Alfalfa, Powder
135 mg

Other Ingredients

Hypromellose Microcrystalline Cellulose Maltodextrin Mannitol Silicon Dioxide Medium Chain Triglyceride
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested Usage: Take 1 capsule daily with a meal.

Warnings & Precautions

Caution: For adults only.

Do not use if pregnant, nursing, or allergic or contraindicated to aspirin. Consult physician if taking medication (especially blood thinners such as warfarin, Coumadin, heparin and aspirin) or have a medical condition.

Discontinue use two weeks prior to surgery or if stomach upset occurs.

Keep out of reach of children.

Not manufactured with wheat, gluten, soy, milk, egg, fish, shellfish or sesame ingredients. Produced in a GMP facility that processes other ingredients containing these allergens.

Do not use if pregnant, nursing, or allergic or contraindicated to aspirin.

Formulation Notes

Vitamin K belongs to a family of fat-soluble compounds that are critical for the proper handling of calcium in the body. Vitamin K is well known for its role in the synthesis of a number of blood coagulation factors and for the formation of strong, healthy bones.

This product is a complete formula with all major forms of the vitamin K family, including vitamin K1 and vitamin K2 (MK-4 and MK-7).

Not manufactured with wheat, gluten, soy, milk, egg, fish, shellfish or sesame ingredients.

Natural color variation may occur in this product.

Supports Bone Health

Two Forms of Vitamin K2 + K1

Cardiovascular Support

MenaQ7

Vegetarian/Vegan

Made and quality tested in the USA with globally sourced ingredients.

Additional Information

Store in a cool, dry place after opening.

Vitamins Family owned since 1968.

GMP Quality Assured

This bottle is made from 100% PCR (post-consumer recycled) resin.

Metadata

Product Details

UPC / SKU7 33739 00997 5
DSLD Entry Date2024-07-25
Product TypeBotanical with Nutrients
FormCapsule
BrandNOW
DSLD ID313777
Data Updated2026-04-11
Research

Research Evidence

332
Research Sources
59
Avg Quality
220
Meta Analysis
56
Systematic Review
30
Rct
16
Clinical Trial
3
Guideline
3
Regulatory Source
1
Narrative Review
1
Other
1
Openfda Safety
A Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Antiplatelet and anticoagulant agents for secondary prevention of stroke and other thromboembolic events in people with antiphospholipid syndrome
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repair
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Antiplatelet agents and anticoagulants for hypertension
Systematic Review The Cochrane database of systematic reviews 2022 PubMed DOI
A Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Factor Xa inhibitors versus vitamin K antagonists for preventing cerebral or systemic embolism in patients with atrial fibrillation
Meta Analysis The Cochrane database of systematic reviews 2013 PubMed DOI
A Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer
Meta Analysis The Cochrane database of systematic reviews 2014 PubMed DOI
View all evidence for Vitamin K →
Compare

Similar Products

View all Vitamin K products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.